Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure

https://doi.org/10.20996/1819-6446-2016-12-5-574-581

Full Text:

Abstract

The review analyzes new treatment for patients with chronic heart failure (CHF) with low ejection fraction – cardiac contractility modulation (CCM). CCM is carried out by supplying electric signals to an absolutely refractory ventricular myocardium, to elicit a positive inotropic effect without increasing myocardial oxygen consumption. These effects are independent on QRS duration; consequently, the therapy might be beneficial for patients who are not candidates for cardiac resynchronization therapy (CRT). It should be noted that the use of CCM treatment of CHF should begin only with maximum active therapy when its efficacy is not enough. It is not an alternative, but complement to the most active treatment of patients. Clinical studies primarily focused on patients with normal QRS duration because the CPT is optimal treatment of patients with prolonged QRS. The article focuses on the prerequisites for the development of the method and discusses the results obtained when evaluating the clinical efficacy and safety of treatment of patients with CHF in randomized clinical trials FIX-HF-3 (n=25), FIX-HF-4 (n=164), FIX-HF-5 (n=428). The total number of patients included into these studies was 617 people. Baseline patient characteristics were similar for all 3 studies. All participants received optimal medical therapy, had a normal QRS duration. All patients were II and III functional class (by NYHA). The studies analyzed the changes in NYHA class, ejection fraction, peak oxygen consumption (VO2), the precursor of brain natriuretic peptide (NT-proBNP) level. Quality of life was assessed by the Minnesota questionnaire; the mortality rate was compared with that predicted by MAGGIC scale. CCM therapy had beneficial effect on the survival and quality of life in patients with CHF. However, more data is needed to assess long-term effects of the CCM therapy.

About the Authors

A. A. Petrukhina
Russian Cardiology Research and Production Complex. Tretya Cherepkovskaya ul. 15a, Moscow, 121552 Russia
Russian Federation

MD, PhD, Researcher of Department of Myocardial Diseases and Heart Failure, Russian Cardiology Research and Production Complex



S. N. Tereshchenko
Russian Cardiology Research and Production Complex. Tretya Cherepkovskaya ul. 15a, Moscow, 121552 Russia
Russian Federation

MD, PhD, Professor, Head of Department of Myocardial Diseases and Heart Failure, Russian Cardiology Research and Production Complex



I. V. Zhirov
Russian Cardiology Research and Production Complex. Tretya Cherepkovskaya ul. 15a, Moscow, 121552 Russia
Russian Federation

MD, PhD, Leading Researcher of Department of Myocardial Diseases and Heart Failure, Russian Cardiology Research and Production Complex



References

1. ESC Guideline for the diagnosis and treatment of acute and chronic heart failure. European Heart Failure. 2016;37:2129-200.

2. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49.

3. Cabrera-Bueno F, Alzueta J, Ruiz-Zamora I, et al. Normalization of left ventricle systolic function after resynchronization therapy in patients with dilated cardiomyopathy. Int J Cardiol. 2012;158:177-9.

4. Abreu CD, Xavier RM, Nascimento JS, Ribeiro AL. Long-term outcome after Cardiac Resynchronization Therapy: a nationwide database. Int J Cardiol. 2012;155:492-3.

5. Lyon AR, Samara MA, Feldman DS. Cardiac contractility modulation therapy in advanced systolic heart failure. Nat Rev Cardiol. 2013; 10: 584-98.

6. Blank M, Goodman R. Initial interactions in electromagnetic field-induced biosynthesis. J Cell Physiol. 2004;199:359-63. doi: 10.1002/jcp.20004.

7. Morita H, Suzuki G, Haddad W, et al. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. J Card Fail. 2003; 9:69-75. doi: 10.1054/jcaf.2003.8.

8. Imai M, Rastogi S, Gupta RC, et al. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol. 2007;49:2120-8. doi: 10.1016/j.jacc.2006.10.082.

9. Dupont E, Matsushita T, Kaba RA, et al. Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol. 2001;33(2):359-71. doi: 10.1006/jmcc.2000.1308.

10. Pappone C, Rosanio S, Burkhoff D, et al. Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2002;90:1307-13. doi: 10.1016/S0002-9149(02)02868-0.

11. Pappone C, Vicedomini G, Salvati A, et al. Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure. Heart Fail Rev. 2001;6:55-60.

12. Kuck KH, Bordachar P, Borggrefe M, et al. New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Eur J Heart Fail. 2013;20:1-20. Europace. 2014;16(1):109-28. doi: 10.1093/europace/eut311.

13. Bogaard MD, Houthuizen P, Bracke FA, et al. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy. Eur J Heart Fail. 2011;13:1126-32. doi: 10.1093/eurjhf/hfr094.

14. Shenkman HJ, Pampati V, Khandelwal AK, et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest. 2002;122:528-34. doi: 10.1378/chest.122.2.528

15. Maggioni AP, Dahlström U, Filippatos G, et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2010;12:1076-84. doi: 10.1093/eurjhf/hfq154.

16. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016 Jul 14;37(27):2129-200. doi: 10.1093/eurheartj/ehw128.

17. Burkhoff D, Ben-Haim SA. Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure. Am J Physiol Heart Circ Physiol. 2005;288:H2550-6. doi: 10.1152/ajpheart.01311.2004.

18. Lawo T, Borggrefe M, Butter C, et al. Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. J Am Coll Cardiol. 2005;46:2229-36. doi: 10.1016/j.jacc.2005.05.093.

19. Sabbah HN, Haddad W, Mika Y, et al. Cardiac contractilty modulation with the impulse dynamics signal: studies in dogs with chronic heart failure. Heart Fail Rev. 2001;6:45-53.

20. Imai M, Rastogi S, Gupta RC, et al. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol. 2007;49:2120-8. doi: 10.1016/j.jacc.2006.10.082.

21. Butter C, Wellnhofer E, Schlegl M, et al. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption. J Card Fail. 2007;13(2):137-42. doi: 10.1016/j.cardfail.2006.11.004.

22. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:3053-9.

23. Pappone C, Augello G, Rosanio S, et al. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol. 2004;15(4):418-27. doi: 10.1046/j.1540-8167.2004.03580.x

24. Yu CM, Chan JY, Zhang Q, et al. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. JACC Cardiovasc Imaging. 2009;2(12):1341-9. doi: 10.1016/j.jcmg.2009.07.011.

25. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113(11):1424-33. doi: 10.1161/CIRCULATIONAHA.105.584102

26. Askenazi J, Alexander JH, Koenigsberg DI, et al. Alteration of left ventricular performance by left bundle branch block simulated with atrioventricular sequential pacing. Am J Cardiol. 1984;53(1):99-104. doi: 10.1016/0002-9149(84)90691-X.

27. Stix G, Borggrefe M, Wolpert C, et al. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J. 2004;25(8):650-5. doi: 10.1016/j.ehj.2004.02.027

28. Butter C, Rastogi S, Minden HH, et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008;51(18):1784-9. doi: 10.1016/j.jacc.2008.01.036.

29. Borggrefe MM, Lawo T, Butter C, et al., Ran-domized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure, Eur Heart J. 2008;29(8):1019- 28. doi: 10.1093/eurheartj/ehn020.

30. Borggrefe M, Burkhoff D. Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. Eur J Heart Fail. 2012;14(7):703-12. doi: 10.1093/eurjhf/hfs078.

31. Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail. 2011 Sep;17(9):710-7. doi: 10.1016/j.cardfail.2011.05.006.

32. Abraham WT, Nademanee K, Volosin K, et al., Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail. 2011;17(9):710-7. doi: 10.1016/j.cardfail.2011.05.006.

33. Schau T, Seifert M, Meyhöfer J, et al. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure. Europace. 2011;13:1436-44. doi: 10.1093/europace/eur153.

34. Kuschyk J, Roeger S, Schneider R, et al. Efficacy and survival in patients with cardiac contractility modulation: Long-term single center experience in 81 patients. Int J Cardiol. 2015 Mar 15;183:76-81. doi: 10.1016/j.ijcard.2014.12.178.

35. Giallauria F, Vigorito C, Piepoli MF, Stewart Coats AJ. Effects of cardiac contractility modulation by nonexcitatory electrical stimulation on exercise capacity and quality of life: An individual patient's data metaanalysis of randomized controlled trials. Int J Cardiol. 2014;175(2):352-7. doi: 10.1016/j.ijcard. 2014.06.005.

36. Kloppe A, Lawo T, Mijic D, et al. Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration. Int J Cardiol. 2016;209:291-5. doi: 10.1016/j.ijcard. 2016.02.001.

37. Liu M, Fang F, Luo XX, et al. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study. Int J Cardiol. 2016;206:122-6. doi: 10.1016/j.ijcard. 2016.01.071.

38. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327: 685–91. doi: 10.1056/NEJM199209033271003.

39. Butter C, Meyhöfer J, Seifert M, et al. First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: Clinical and technical aspects of combined therapies. Eur J Heart Fail. 2007; 9: 955-8. doi: 10.1016/j.ejheart.2007.05.012.


For citation:


Petrukhina A.A., Tereshchenko S.N., Zhirov I.V. Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure. Rational Pharmacotherapy in Cardiology. 2016;12(5):574-581. (In Russ.) https://doi.org/10.20996/1819-6446-2016-12-5-574-581

Views: 398


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)